SCHEMBL6468413

SCHEMBL6468413

CCc1ccnc(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10532368 0.92 LOXL2 (0.55)
SCHEMBL10238963 0.83 LOXL2 (0.59)
SCHEMBL12893452 0.79 LOXL2 (0.55)
SCHEMBL1211655 0.78 LOXL2 (0.53)
SCHEMBL22241346 0.78 LOXL2 (0.44)
SCHEMBL116309 0.77
SCHEMBL2642497 0.77
SCHEMBL1348600 0.77
SCHEMBL29893902 0.77
SCHEMBL3994643 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118084724-A Method for preparing aryl nitrile by copper-catalyzed oxidation and cleavage of alkyl-substituted aromatic ring and aromatic heterocyclic carbon-carbon bond 中国科学院大连化学物理研究所 2024-05-28 CN disclosed
US-20230295131-A1 INHIBITORS OF RHO-ASSOCIATED COILED-COIL KINASE ANGION BIOMEDICA CORP. 2023-09-21 US disclosed
US-11737463-B2 Pyridine and pyrazine compounds BASF SE (DE) 2023-08-29 US disclosed
US-20230257362-A1 TRIAZOLONE COMPOUND MEDSHINE DISCOVERY INC. (CN) 2023-08-17 US disclosed
EP-4223739-A1 3,6-BIS(CYANOMETHYLIDENE)CYCLOHEXA-1,4-DIENE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONIC DEVICES Novaled GmbH (DE) 2023-08-09 EP disclosed
US-20230203010-A1 BICYCLIC AMINE CDK12 INHIBITORS INCYTE CORPORATION 2023-06-29 US disclosed
US-20230142119-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-11 US disclosed
US-11584738-B2 LPA receptor antagonists and uses thereof GILEAD SCIENCES, INC. (US) 2023-02-21 US disclosed
US-11566001-B2 Hepatitis B capsid assembly modulators VenatoRx Pharmaceuticals, Inc. (US) 2023-01-31 US disclosed
US-20230025510-A1 BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2023-01-26 US disclosed
US-20080293718-A1 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia ASTRAZENECA AB (SE) 2008-11-27 US disclosed
US-20070129367-A1 Pyridine derivatives as cb2 receptor modulators GLAXO GROUP LIMITED (GB) 2007-06-07 US disclosed
US-20070129367-A1 Pyridine derivatives as cb2 receptor modulators GLAXO GROUP LIMITED (GB) 2007-06-07 US disclosed
EP-0799207-B1 PROCESS FOR THE PREPARATION OF FLUORINATED HETEROCYCLIC COMPOUNDS F2 CHEMICALS LIMITED (GB) 1999-06-09 EP disclosed
US-5859255-A Process for the preparation of fluorinated heterocyclic compounds F2 CHEMICALS LTD. (GB) 1999-01-12 US disclosed
CN-1170406-A Preparation of fluorinated heterocyclic compounds F2 CHEMICAL PRODUCTS LTD (GB) 1998-01-14 CN disclosed
EP-0799207-A1 PROCESS FOR THE PREPARATION OF FLUORINATED HETEROCYCLIC COMPOUNDS BNFL FLUOROCHEMICALS LTD. (GB) 1997-10-08 EP disclosed
WO-1996019456-A1 PROCESS FOR THE PREPARATION OF FLUORINATED HETEROCYCLIC COMPOUNDS BNFL FLUOROCHEMICALS LTD. (GB) 1996-06-27 WO disclosed
WO-1996003379-A1 THE ALKOXYLATION OF HETEROCYCLIC COMPOUNDS IN THE PRESENCE OF FLUORINE BNFL FLUOROCHEMICALS LTD. (GB) 1996-02-08 WO disclosed
US-4786733-A CONTACTING WITH FLUORINE GAS ALLIED-SIGNAL INC. (US) 1988-11-22 US disclosed